JP2020531521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531521A5 JP2020531521A5 JP2020511255A JP2020511255A JP2020531521A5 JP 2020531521 A5 JP2020531521 A5 JP 2020531521A5 JP 2020511255 A JP2020511255 A JP 2020511255A JP 2020511255 A JP2020511255 A JP 2020511255A JP 2020531521 A5 JP2020531521 A5 JP 2020531521A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- amino acid
- concentration
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762548772P | 2017-08-22 | 2017-08-22 | |
| US62/548,772 | 2017-08-22 | ||
| PCT/US2018/047502 WO2019040608A1 (en) | 2017-08-22 | 2018-08-22 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE SCHEMES CONTAINING ANTI-ALPHA (V) BETA ANTIBODIES (6) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020531521A JP2020531521A (ja) | 2020-11-05 |
| JP2020531521A5 true JP2020531521A5 (https=) | 2021-09-30 |
Family
ID=63452750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511255A Pending JP2020531521A (ja) | 2017-08-22 | 2018-08-22 | 抗アルファ（ｖ）ベータ（６）抗体を含有する医薬組成物及び投薬計画 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210363259A1 (https=) |
| EP (1) | EP3672632A1 (https=) |
| JP (1) | JP2020531521A (https=) |
| KR (1) | KR20200044066A (https=) |
| CN (1) | CN111201036A (https=) |
| AU (1) | AU2018322475A1 (https=) |
| BR (1) | BR112020003498A2 (https=) |
| CA (1) | CA3073286A1 (https=) |
| MA (1) | MA49948A (https=) |
| MX (1) | MX2020001851A (https=) |
| WO (1) | WO2019040608A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11827709B2 (en) | 2019-12-05 | 2023-11-28 | Seagen Inc. | Anti-AVB6 antibodies and antibody-drug conjugates |
| WO2026011013A1 (en) | 2024-07-02 | 2026-01-08 | Epibiologics, Inc. | Binding agents and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US6267958B1 (en) * | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| ATE511850T1 (de) | 1997-08-08 | 2011-06-15 | Univ California | Behandlung von blasenfibrose mit antikörpern gegen alpha-v-beta-6-integrin |
| US8658773B2 (en) * | 2011-05-02 | 2014-02-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
| MXPA05010555A (es) * | 2003-04-04 | 2006-03-09 | Genentech Inc | Formulaciones de proteina y anticuerpo de alta concentracion. |
| AU2005299716B2 (en) * | 2004-10-22 | 2012-09-06 | Amgen Inc. | Methods for refolding of recombinant antibodies |
| GT200600031A (es) * | 2005-01-28 | 2006-08-29 | Formulacion anticuerpo anti a beta | |
| CN104072614B (zh) * | 2005-07-08 | 2017-04-26 | 生物基因Ma公司 | 抗-αvβ6 抗体及其用途 |
| AR060487A1 (es) * | 2006-04-21 | 2008-06-18 | Xoma Technology Ltd | Composiciones farmaceuticas de antagonistas del anticuerpo anti- cd40 |
| JP2010506944A (ja) * | 2006-10-19 | 2010-03-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | インテグリンαＶβ６のアンタゴニストを用いる慢性喘息の処置および予防 |
| CA2674608A1 (en) * | 2007-01-09 | 2008-07-17 | Wyeth | Anti-il-13 antibody formulations and uses thereof |
| PE20091174A1 (es) * | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
| EP3409289B1 (en) * | 2010-02-26 | 2020-09-30 | Novo Nordisk A/S | Stable antibody containing compositions |
| CA2835438A1 (en) * | 2011-05-25 | 2012-11-29 | Intermune, Inc. | Pirfenidone and anti-fibrotic therapy in selected patients |
| IL312865B2 (en) * | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| EP3383435A4 (en) * | 2015-11-30 | 2019-07-10 | Medimmune, LLC | OPTIMIZED RATES OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS HAVING HIGH CONCENTRATIONS IN PROTEIN-BASED THERAPEUTICS |
-
2018
- 2018-08-22 AU AU2018322475A patent/AU2018322475A1/en not_active Abandoned
- 2018-08-22 MX MX2020001851A patent/MX2020001851A/es unknown
- 2018-08-22 US US16/640,422 patent/US20210363259A1/en not_active Abandoned
- 2018-08-22 WO PCT/US2018/047502 patent/WO2019040608A1/en not_active Ceased
- 2018-08-22 JP JP2020511255A patent/JP2020531521A/ja active Pending
- 2018-08-22 EP EP18762993.6A patent/EP3672632A1/en not_active Withdrawn
- 2018-08-22 CN CN201880065802.7A patent/CN111201036A/zh active Pending
- 2018-08-22 MA MA049948A patent/MA49948A/fr unknown
- 2018-08-22 CA CA3073286A patent/CA3073286A1/en not_active Abandoned
- 2018-08-22 BR BR112020003498-3A patent/BR112020003498A2/pt not_active IP Right Cessation
- 2018-08-22 KR KR1020207008234A patent/KR20200044066A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12544438B2 (en) | Pharmaceutical products and stable liquid compositions of IL-17 antibodies | |
| JP2023517236A5 (https=) | ||
| JP2019523295A5 (https=) | ||
| JP2008528638A5 (https=) | ||
| JP2020531520A5 (https=) | ||
| AU2015313827C1 (en) | Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients | |
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| US20250011416A1 (en) | Methods for the treatment of cardiovascular disease | |
| JP2020531521A5 (https=) | ||
| US20190322734A1 (en) | Treatment paradigm | |
| WO2023240031A1 (en) | Compositions and methods for treating postural tachycardia syndrome | |
| IL292493B1 (en) | Stable aqueous anti-TFPI antibody formulation | |
| TW201828984A (zh) | 使用介白素-17(il-17)拮抗劑治療痤瘡的方法 | |
| JP2025536574A (ja) | 抗ｃｔｌａ抗体組成物及び関連方法 | |
| JP2022524814A5 (https=) | ||
| WO2025255300A1 (en) | FORMULATIONS FOR ANTI-N3pGlu AMYLOID BETA ANTIBODIES | |
| WO2026072993A1 (en) | Methods for treatment of metabolic dysfunction-associated steatohepatitis with an anti-tl1a antibody | |
| HK40108489A (en) | Pharmaceutical products and stable liquid compositions of il-17 antibodies | |
| WO2025072725A1 (en) | Methods for the treatment of cardiovascular disease | |
| WO2026024319A1 (en) | Treatment of obesity and obstructive sleep apnea | |
| RU2021129295A (ru) | Фармацевтические композиции, содержащие антитела к lingo-1 | |
| HK1237260A1 (en) | Pharmaceutical products and stable liquid compositions of il-17 antibodies | |
| HK1237260B (en) | Pharmaceutical products and stable liquid compositions of il-17 antibodies |